Chronic inhibition of endoplasmic reticulum stress and inflammation prevents ischaemia-induced vascular pathology in type II diabetic mice

Journal of Pathology

Volumn 227, Issue 2, 2012, Pages 165-174

  Amin, Ali ^a   Choi, Soo Kyoung ^a   Galan, Maria ^a   Kassan, Modar ^a   Partyka, Megan ^a   Kadowitz, Philip ^a   Henrion, Daniel ^b   Trebak, Mohamed ^c   Belmadani, Souad ^d   Matrougui, Khalid ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CNRS   (France)

^c ALBANY MEDICAL COLLEGE   (United States)

^d LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

blood flow; db db mice; ER stress; inflammation; neovascularization

Indexed keywords

ADIPONECTIN; CHOLESTEROL; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TAUROURSODEOXYCHOLIC ACID; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLOOD FLOW; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CONTROLLED STUDY; DRUG MECHANISM; ENDOPLASMIC RETICULUM STRESS; GLUCOSE BLOOD LEVEL; INFLAMMATION; ISCHEMIA; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; REAL TIME POLYMERASE CHAIN REACTION; VASCULAR DISEASE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; BLOOD VESSELS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DISEASE MODELS, ANIMAL; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; HINDLIMB; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; ISCHEMIA; MACROPHAGES; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; RECOVERY OF FUNCTION; REGIONAL BLOOD FLOW; SIGNAL TRANSDUCTION; TAUROCHENODEOXYCHOLIC ACID; TIME FACTORS;

EID: 84862824419     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.3960     Document Type: Article

References (32)

1. Harding HP, Ron D,. Endoplasmic reticulum stress and the development of diabetes: a review. Diabetes 2002; 51 (Suppl 3): S455-S461.
2. Mannava K, Money SR,. Current management of peripheral arterial occlusive disease: a review of pharmacologic agents and other interventions. Am J Cardiovasc Drugs 2007; 7: 59-66.
3. Cooke JP,. NO and angiogenesis. Atheroscler Suppl 2003; 4: 53-60.
4. Bernardini G, Ribatti D, Spinetti G, et al., Analysis of the role of chemokines in angiogenesis. J Immunol Methods 2003; 273: 83-101.
5. Morbidelli L, Donnini S, Ziche M,. Role of nitric oxide in the modulation of angiogenesis. Curr Pharm Des 2003; 9: 521-530.
6. Amin AH, Abd Elmageed ZY, Nair D, et al., Modified multipotent stromal cells with epidermal growth factor restore vasculogenesis and blood flow in ischemic hind-limb of type II diabetic mice. Lab Invest 2010; 90: 985-996.
7. Silvestre JS, Levy BI,. [Diabetes and peripheral arterial occlusive disease: therapeutic potential and pro-angiogenic strategies]. Ann Cardiol Angeiol (Paris) 2006; 55: 100-103.
8. Uchida C, Haas TL,. Evolving strategies in manipulating VEGF/VEGFR signaling for the promotion of angiogenesis in ischemic muscle. Curr Pharm Des 2009; 15: 411-421.
9. Urbich C, Dimmeler S,. Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. Kidney Int 2005; 67: 1672-1676.
10. Belmadani S, Matrougui K, Kolz C, et al., Amplification of coronary arteriogenic capacity of multipotent stromal cells by epidermal growth factor. Arterioscler Thromb Vasc Biol 2009; 29: 802-808.
11. Hansson GK,. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695.
12. Packard RR, Libby P,. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 2008; 54: 24-38.
13. Fearon WF, Fearon DT,. Inflammation and cardiovascular disease: role of the interleukin-1 receptor antagonist. Circulation 2008; 117: 2577-2579.
14. Loppnow H, Westphal E, Buchhorn R, et al., Interleukin-1 and related proteins in cardiovascular disease in adults and children. Shock 2001; 16 (Suppl 1): 3-9.
15. Dinarello CA, Savage N,. Interleukin-1 and its receptor. Crit Rev Immunol 1989; 9: 1-20.
16. Dinarello CA, Donath MY, Mandrup-Poulsen T,. Role of IL-1beta in type 2 diabetes. Curr Opin Endocrinol Diabetes Obes 2010; 17: 314-321.
17. Kumar D, Branch BG, Pattillo CB, et al., Chronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesis. Proc Natl Acad Sci U S A 2008; 105: 7540-7545.
18. Sarkar K, Fox-Talbot K, Steenbergen C, et al., Adenoviral transfer of HIF-1alpha enhances vascular responses to critical limb ischemia in diabetic mice. Proc Natl Acad Sci U S A 2009; 106: 18769-18774.
19. Ozcan U, Cao Q, Yilmaz E, et al., Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004; 306: 457-461.
20. Ozcan U, Yilmaz E, Ozcan L, et al., Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006; 313: 1137-1140.
21. Belmadani S, Palen DI, Gonzalez-Villalobos RA, et al., Elevated epidermal growth factor receptor phosphorylation induces resistance artery dysfunction in diabetic db/db mice. Diabetes 2008; 57: 1629-1637.
22. Gonzalez-Villalobos RA, Satou R, Seth DM, et al., Angiotensin-converting enzyme-derived angiotensin II formation during angiotensin II-induced hypertension. Hypertension 2009; 53: 351-355.
23. Jacobi J, Tam BY, Wu G, et al., Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hindlimb ischemia. Circulation 2004; 110: 2424-2429.
24. Belmadani S, Zerfaoui M, Boulares HA, et al., Microvessel vascular smooth muscle cells contribute to collagen type I deposition through ERK1/2 MAP kinase, alphavbeta3-integrin, and TGF-beta1 in response to ANG II and high glucose. Am J Physiol Heart Circ Physiol 2008; 295: H69-H76.
25. Su J, Lucchesi PA, Gonzalez-Villalobos RA, et al., Role of advanced glycation end products with oxidative stress in resistance artery dysfunction in type 2 diabetic mice. Arterioscler Thromb Vasc Biol 2008; 28: 1432-1438.
26. Schmidt HH, Lohmann SM, Walter U,. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim Biophys Acta 1993; 1178: 153-175.
27. Ng WH, Moochhala S, Yeo TT, et al., Nitric oxide and subarachnoid hemorrhage: elevated level in cerebrospinal fluid and their implications. Neurosurgery 2001; 49: 622-626; discussion 626-627.
28. Liu X, Li Y, Liu Y, et al., Endothelial progenitor cells (EPCs) mobilized and activated by neurotrophic factors may contribute to pathologic neovascularization in diabetic retinopathy. Am J Pathol 2010; 176: 504-515.
29. Fadini GP, Sartore S, Schiavon M, et al., Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. Diabetologia 2006; 49: 3075-3084.
30. Humpert PM, Eichler H, Lammert A, et al., Adult vascular progenitor cells and tissue regeneration in metabolic syndrome. Vasa 2005; 34: 73-78, 80.
31. Larsen CM, Faulenbach M, Vaag A, et al., Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007; 356: 1517-1526.
32. Rother KI,. Diabetes treatmentâbridging the divide. N Engl J Med 2007; 356: 1499-1501.